Yiding joined ALS Therapy Development Institute in 2015. She has 20 years of experience in bench research in both biopharmaceuticals and academics, where she was involved in a broad range of technology for in vitro research. Her previous experience focused on mouse genetics modeling of human disease, inflammation kinase assays, cancer biology cell-based assays, siRNA DMPK study, and cell automation. Her specialties include cell assay development and gene construction.